Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Permeability brain

Specific barriers may serve to limit dmg distribution. The placental barrier is of obvious importance to dmg action in the fetus. Dmg transfers across the placenta primarily by Hpid solubiHty. Hence, this barrier is not particularly restrictive. Similarly, the Hpid solubiHty of a dmg is a primary deterrninant in access to the brain and cerebrospinal fluid. Generally, hydrophilic or charged dmgs can also penetrate to these latter areas, but the result is slow and incomplete. The blood brain barrier is composed of cells having tight junctions which are much less permeable to solutes than are the endotheHal cells of other tissues. [Pg.269]

Toxicity. The toxicity of barium compounds depends on solubility (47—49). The free ion is readily absorbed from the lung and gastrointestinal tract. The mammalian intestinal mucosa is highly permeable to Ba " ions and is involved in the rapid flow of soluble barium salts into the blood. Barium is also deposited in the muscles where it remains for the first 30 h and then is slowly removed from the site (50). Very Httle is retained by the fiver, kidneys, or spleen and practically none by the brain, heart, and hair. [Pg.483]

The blood-brain barrier (BBB) forms a physiological barrier between the central nervous system and the blood circulation. It consists of glial cells and a special species of endothelial cells, which form tight junctions between each other thereby inhibiting paracellular transport. In addition, the endothelial cells of the BBB express a variety of ABC-transporters to protect the brain tissue against toxic metabolites and xenobiotics. The BBB is permeable to water, glucose, sodium chloride and non-ionised lipid-soluble molecules but large molecules such as peptides as well as many polar substances do not readily permeate the battier. [Pg.272]

Johanson CE. 1980. Permeability and vascularity of the developing brain Cerebellum vs cerebral cortex. Brain Res 190 3-16. [Pg.214]

Liu X, Tu M, Kelly RS, Chen C and Smith BJ. Development of a computational approach to predict blood-brain barrier permeability. Drug Metab Dispos 2004 32 132-9. [Pg.510]

MW is often taken as the size descriptor of choice, while it is easy to calculate and is in the chemist s mind. However, other size and shape properties are equally simple to calculate, and may offer a better guide to estimate potential for permeability. Thus far no systematic work has been reported investigating this in detail. Cross-sectional area Ad obtained from surface activity measurements have been reported as a useful size descriptor to discriminate compounds which can access the brain (Ad<80A ) of those that are too large to cross the blood-brain barrier (BBB) [55]. Similar studies have been performed to define a cut-off for oral absorption [56]. [Pg.33]

Suomalainen, P., Johans, G., Soderlund, T., Kinnunen, P. K. Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability. J. Med. Chem. 2004, 47, 1783-1788. [Pg.50]

D. J., Jeffrey, P. Improving the in vitro prediction of in vivo centtal nervous system penetration Integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain. [Pg.51]

Fig. 3.4 Permeability profiles for (a) warfarin (acid), (b) propranolol (base) and (c) morphine (ampholyte) based on a BBB PAMPA model (plON) composed of animal brain extract of lipids. The data (unpublished) were analyzed with the pCEL-X program (plON), with the refined parameters indicated in the three frames. In all three cases, there was evidence for the permeation of charged... Fig. 3.4 Permeability profiles for (a) warfarin (acid), (b) propranolol (base) and (c) morphine (ampholyte) based on a BBB PAMPA model (plON) composed of animal brain extract of lipids. The data (unpublished) were analyzed with the pCEL-X program (plON), with the refined parameters indicated in the three frames. In all three cases, there was evidence for the permeation of charged...
Dudley, A., Beliveau, R. P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its predicfion using an in comho PAM PA model, (under review)... [Pg.83]

Hansch and Leo [13] described the impact of Hpophihdty on pharmacodynamic events in detailed chapters on QSAR studies of proteins and enzymes, of antitumor drugs, of central nervous system agents as well as microbial and pesticide QSAR studies. Furthermore, many reviews document the prime importance of log P as descriptors of absorption, distribution, metabolism, excretion and toxicity (ADMET) properties [5-18]. Increased lipophilicity was shown to correlate with poorer aqueous solubility, increased plasma protein binding, increased storage in tissues, and more rapid metabolism and elimination. Lipophilicity is also a highly important descriptor of blood-brain barrier (BBB) permeability [19, 20]. Last, but not least, lipophilicity plays a dominant role in toxicity prediction [21]. [Pg.358]

While evidence of a breakdown in the permeability of the blood-brain barrier in Alzheimer s disease has been presented (Scheibel, 1987), it continues to be a matter of contention (Rozemuller et 1988). [Pg.253]

Oa radicals in arachidonate-induced increased blood-brain barrier permeability to proteins. Am. J. Physiol. 251, H693-699. [Pg.261]

Tanno, H., Nockels, R.P., Pitts, L.H. and Noble, L.J. (1992). Breakdown of the blood brain barrier after fluid percussion brain injury in the rat. 2. Effect of hypoxia on permeability to plasma proteins. J. Neurotrauma, 9, 335-347. [Pg.276]

Whereas the relationship of solute permeability with lipophilicity has been studied in a large number of in vivo systems (including intestinal absorption models [54,55], blood-brain [56 58] and blood nerve [59] barrier models, and cell culture models [60 62], to name just a few), numerous in vitro model systems have been developed to overcome the complexity of working with biological membranes [63-66]. Apart from oil-water systems that are discussed here, the distribution of a solute between a water phase and liposomes is... [Pg.728]

BBB PAMPA Blood brain barrier parallel artificial membrane permeability assay... [Pg.176]

Poduslo JF, Curran GL, Kumar A, Frangione B, Soto C. Beta-sheet breaker peptide inhibitor of Alzheimer s amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma. J Neurobiol 1999 39 371-382. [Pg.279]


See other pages where Permeability brain is mentioned: [Pg.141]    [Pg.536]    [Pg.141]    [Pg.536]    [Pg.164]    [Pg.216]    [Pg.324]    [Pg.912]    [Pg.928]    [Pg.946]    [Pg.24]    [Pg.501]    [Pg.501]    [Pg.237]    [Pg.200]    [Pg.232]    [Pg.244]    [Pg.26]    [Pg.27]    [Pg.75]    [Pg.66]    [Pg.67]    [Pg.126]    [Pg.245]    [Pg.41]    [Pg.146]    [Pg.253]    [Pg.819]    [Pg.154]    [Pg.159]    [Pg.201]    [Pg.1035]    [Pg.540]   
See also in sourсe #XX -- [ Pg.264 ]




SEARCH



© 2024 chempedia.info